{
  "docId": "019de075-89b3-76e0-854f-751e522d63c5",
  "docSlug": "a1e66a21a5f72ac122dd8f79d63b40d9",
  "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
  "authorId": "equillium",
  "authorName": "Equillium",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 29,
  "pageCount": 39,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a four-column structure to explain the biological rationale, molecular nature, mechanism of action, and clinical status.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-89b3-76e0-854f-751e522d63c5/29",
  "deckHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5",
  "deckJsonHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5.json",
  "deckAnchorHref": "/decks/019de075-89b3-76e0-854f-751e522d63c5#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.09,
        "w": 0.94,
        "x": 0.03,
        "y": 0.17
      },
      "kind": "callout",
      "text": "IL-15 & IL-21 are key cytokines driving GI inflammation in celiac disease and IBD",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "033c9d3f-9069-46c3-9038-6ba9a4eaf50f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.78,
        "y": 0.54
      },
      "kind": "list",
      "text": "Currently in a Phase 1 first-in-human SAD/MAD study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46cae2ec-e092-4030-a549-a2d22a1e322f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.28,
        "y": 0.54
      },
      "kind": "list",
      "text": "PEGylated peptide based on the D-helix of γc cytokines selectively inhibiting IL-15 & IL-21 signaling; Administered as subcutaneous injection",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d2db1fb-8752-4d6e-9828-7accfacae1a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.22,
        "x": 0.53,
        "y": 0.54
      },
      "kind": "list",
      "text": "Inhibits the IL-15 & IL-21 induced signaling pathways in CeD patient-derived T cells organoid cultures; Prevents intestinal tissue damage in a humanized mouse model",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc1dc9f5-2ffe-462f-817c-dc05b9dc4d70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.03,
        "y": 0.54
      },
      "kind": "list",
      "text": "Natural biological synergy of IL-15 and IL-21 (T and B cell biology); IL-15 a validated target in the treatment of celiac disease",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0939440-bb0e-4b8c-aeb7-4acb3aa73af0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.12,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "GI = gastrointestinal; IBD = inflammatory bowel disease; CeD = celiac disease; SAD = single ascending dose; MAD = multiple ascending dose; 1) Sarra et al., Mucosal Immunol, 2013; 2) Kooy-Winkelaar et al., Gut, 2016; 3) Ciszewski et al., Gastroenterology, 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd427983-67f7-4cb8-be69-8b78b32071a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.68,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "EQ102: A First-in-class Bi-Specific Cytokine Inhibitor",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9185a9a1-a028-4d0c-9c06-d6d54b981782",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}